VUNAKIZUMAB
UNII Y4U029R8MS

Substance Identification & Data

This profile provides standardized clinical and technical data for Vunakizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y4U029R8MS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1792181-33-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Y4U029R8MS

CAS Registry Number

1792181-33-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VUNAKIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152923

National Cancer Institute reference terminology for clinical and research data.

INN ID

10399

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vunakizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VUNAKIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(INTERLEUKIN) (HUMAN-MUS MUSCULUS MONOCLONAL SHR-1314 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SHR-1314 LIGHT CHAIN, DIMER

VUNAKIZUMAB [INN]

VUNAKIZUMAB [WHO-DD]